Fatty acids and glucolipotoxicity in the pathogenesis of Type 2 diabetes

Biochemical Society Transactions

Volumn 36, Issue 3, 2008, Pages 348-352

  Cnop, Miriam ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

Apoptosis; Diabetes mellitus; Lipoprotein; Lipotoxicily; Non esterified fatty acid; Pancreatic cell

Indexed keywords

FATTY ACID;

APOPTOSIS; CELL DEATH; CELL LOSS; CELLULAR STRESS RESPONSE; CONFERENCE PAPER; CYTOTOXICITY; ENDOPLASMIC RETICULUM STRESS; FAT INTAKE; GENETIC PREDISPOSITION; HUMAN; INSULIN DEFICIENCY; INSULIN RELEASE; INSULIN RESISTANCE; LIPID DIET; MOLECULAR MECHANICS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PANCREAS ISLET BETA CELL; PATHOGENESIS; PRIORITY JOURNAL;

ANIMALS; DIABETES MELLITUS, TYPE 2; FATTY ACIDS; GLUCOSE; HUMANS;

EID: 45249122276     PISSN: 03005127     EISSN: None     Source Type: Journal    
DOI: 10.1042/BST0360348     Document Type: Conference Paper

References (63)

1. Hill, J.O. (2006) Understanding and addressing the epidemic of obesity: an energy balance perspective. Endocr. Rev. 27, 750-761
2. Zimmet, P., Alberti, K.G. and Shaw, J. (2001) Global and societal implications of the diabetes epidemic. Nature 414, 782-787
3. Kahn, S.E. (2003) The relative contributions of insulin resistance and β-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia 46, 3-19
4. Cnop, M., Vidal, J., Hull, R.L., Utzschneider, K.M., Carr, D.B., Schraw, T., Scherer, P.E., Boyko, E.J., Fujimoto, W.Y. and Kahn, S.E. (2007) Progressive loss of β-cell function leads to worsening glucose tolerance in first-degree relatives of subjects with type 2 diabetes. Diabetes Care 30, 677-682
5. Wagenknecht, L.E., Langefeld, C.D., Scherzinger, A.L., Norris, J.M., Haffner, S.M., Saad, M.F. and Bergman, R.N. (2003) Insulin sensitivity, insulin secretion, and abdominal fat: the Insulin Resistance Atherosclerosis Study (IRAS) Family Study. Diabetes 52, 2490-2496
6. Kriketos, A.D., Carey, D.G., Jenkins, A.B., Chisholm, D.J., Furier, S.M. and Campbell, L.V. (2003) Central fat predicts deterioration of insulin secretion index and fasting glycaemia: 6-year follow-up of subjects at varying risk of type 2 diabetes mellitus. Diabetic Med. 20, 294-300
7. Pinnick, K.E., Collins, S.C., Londos, C., Gauguier, D., Clark, A. and Fielding, B.A. (2008) Pancreatic ectopic fat is characterized by adipocyte infiltration and altered lipid composition. Obesity 16, 522-530
8. Tushuizen, M.E., Bunck, M.C., Pouwels, P.J., Bontemps, S., van Waesberghe, J.H., Schindhelm, R.K., Mari, A., Heine, R.J. and Diamant, M. (2007) Pancreatic fat content and β-cell function in men with and without type 2 diabetes. Diabetes Care 30, 2916-2921
9. Handschin, C., Choi, C.S., Chin, S., Kim, S., Kawamori, D., Kurpad, A.J., Neubauer, N., Hu, J., Mootha, V.K., Kim, Y.B. et al. (2007) Abnormal glucose homeostasis in skeletal muscle-specific PGC-1α knockout mice reveals skeletal muscle-pancreatic β-cell crosstalk. J. Clin. Invest. 117, 3463-3474
10. Butler, A.E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R.A. and Butler, P.C. (2003) β-Cell deficit and increased β-cell apoptosis in humans with type 2 diabetes. Diabetes 52, 102-110
11. Clark, A., Wells, C.A., Buley, I.D., Cruickshank, J.K., Vanhegan, R.I., Matthews, D.R., Cooper, G.J., Holman, R.R. and Turner, R.C. (1988) Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: guantitative changes in the pancreas in type 2 diabetes. Diabetes Res. 9, 151-159
12. Klöppel, G., Löhr, M., Habich, K., Oberholzer, M. and Heitz, P.U. (1985) Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited. Surv. Synth. Pathol. Res. 4, 110-125
13. Sakuraba, H., Mizukami, H., Yagihashi, N., Wada, R., Hanyu, C. and Yagihashi, S. (2002) Reduced β-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese Type II diabetic patients. Diabetologia 45, 85-96
14. Gerken, T., Girard, C.A., Tung, Y.C., Webby, C.J., Saudek, V., Hewitson, K.S., Yeo, G.S., McDonough, M.A., Cunliffe, S., McNeill, L.A. et al. (2007) The obesity-associated FTO gene encodes a 2-oxoglutarate dependent nucleic acid demethylase. Science 318, 1469-1472
15. Frayling, T.M. (2007) Genome-wide association studies provide new insights into type 2 diabetes aetiology. Nat. Rev. Genet. 8, 657-662
16. Lindsay, R.S., Funahashi, T., Hanson, R.L., Matsuzawa, Y., Tanaka, S., Tataranni, P.A., Knowler, W.C. and Krakoff, J. (2002) Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 360, 57-58
17. Pankow, J.S., Duncan, B.B., Schmidt, M.I., Ballantyne, C.M., Couper, D.J., Hoogeveen, R.C. and Golden, S.H. (2004) Fasting plasma free fatty acids and risk of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes Care 27, 77-82
18. Paolisso, G., Tataranni, P.A., Foley, J.E., Bogardus, C., Howard, B.V. and Ravussin, E. (1995) A high concentration of fasting plasma non-esterified fatty acids is a risk factor for the development of NIDDM. Diabetologia 38, 1213-1217
19. Wang, L., Folsom, A.R., Zheng, Z.J., Pankow, J.S. and Eckfeldt, J.H. (2003) Plasma fatty acid composition and incidence of diabetes in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am. J. Clin. Nutr. 78, 91-98
20. Kharroubi, I., Rasschaert, J., Eizirik, D.L. and Cnop, M. (2003) Expression of adiponectin receptors in pancreatic β-cells. Biochem. Biophys. Res. Commun. 312, 1118-1122
21. Kaiyala, K.J., Prigeon, R.L., Kahn, S.E., Woods, S.C., Porte, Jr, D. and Schwartz, M.W. (1999) Reduced β-cell function contributes to impaired glucose tolerance in dogs made obese by high-fat feeding. Am. J. Physiol. 277, E659-E667
22. Winzell, M.S., Magnusson, C. and Ahren, B. (2007) Temporal and dietary fat content-dependent islet adaptation to high-fat feeding-induced glucose intolerance in mice. Metabolism 56, 122-128
23. Carpentier, A., Mittelman, S.D., Lamarche, B., Bergman, R.N., Giacca, A. and Lewis, G.F. (1999) Acute enhancement of insulin secretion by FFA in humans is lost with prolonged FFA elevation. Am. J. Physiol. 276, E1055-E1066
24. Kashyap, S., Belfort, R., Gastaldelli, A., Pratipanawatr, T., Berria, R., Pratipanawatr, W., Bajaj, M., Mandarino, L., DeFronzo, R. and Cusi, K. (2003) A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes. Diabetes 52, 2461-2474
25. Paolisso, G., Gambardella, A., Amato, L., Tortoriello, R., D'Amore, A., Varricchio, M. and D'Onofrio, F. (1995) Opposite effects of short- and long-term fatty acid infusion on insulin secretion in healthy subjects. Diabetologia 38, 1295-1299
26. Sako, Y. and Grill, V.E. (1990) A 48-hour lipid infusion in the rat time-dependently inhibits glucose-induced insulin secretion and β-cell oxidation through a process likely coupled to fatty acid oxidation. Endocrinology 127, 1580-1589
27. Bollheimer, L.C., Skelly, R.H., Chester, M.W., McGarry, J.D. and Rhodes, C.J. (1998) Chronic exposure to free fatty acid reduces pancreatic β-cell insulin content by increasing basal insulin secretion that is not compensated for by a corresponding increase in proinsulin biosynthesis translation. J. Clin. Invest. 101, 1094-1101
28. Kelpe, C.L., Moore, P.C., Parazzoli, S.D., Wicksteed, B., Rhodes, C.J. and Poitout, V. (2003) Palmitate inhibition of insulin gene expression is mediated at the transcriptional level via ceramide synthesis. J. Biol. Chem. 278, 30015-30021
29. Zhou, Y.P. and Grill, V. (1995) Long term exposure to fatty acids and ketones inhibits B-cell functions in human pancreatic islets of Langerhans. J. Clin. Endocrinol. Metab. 80, 1584-1590
30. Zhou, Y.P. and Grill, V.E. (1994) Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle. J. Clin. Invest. 93, 870-876
31. Cnop, M., Hannaert, J.C., Hoorens, A., Eizirik, D.L. and Pipeleers, D.G. (2001) Inverse relationship between cytotoxicity of free fatty acids in pancreatic islet cells and cellular triglyceride accumulation. Diabetes 50, 1771-1777
32. Kharroubi, I., Ladriere, L., Cardozo, A.K., Dogusan, Z., Cnop, M. and Eizirik, D.L. (2004) Free fatty acids and cytokines induce pancreatic β-cell apoptosis by different mechanisms: role of nuclear factor-κB and endoplasmic reticulum stress. Endocrinology 145, 5087-5096
33. Grupping, A.Y., Cnop, M., Van Schravendijk, C.F., Hannaert, J.C., Van Berkel, T.J. and Pipeleers, D.G. (1997) Low density lipoprotein binding and uptake by human and rat islet β-cells. Endocrinology 138, 4064-4068
34. Cnop, M., Grupping, A., Hoorens, A., Bouwens, L., Pipeleers-Marichal, M. and Pipeleers, D. (2000) Endocytosis of low-density lipoprotein by human pancreatic β-cells and uptake in lipid-storing vesicles, which increase with age. Am. J. Pathol. 156, 237-244
35. Cnop, M., Hannaert, J.C., Grupping, A.Y. and Pipeleers, D.G. (2002) Low density lipoprotein can cause death of islet β-cells by its cellular uptake and oxidative modification. Endocrinology 143, 3449-3453
36. Hull, R.L., Andrikopoulos, S., Verchere, C.B., Vidal, J., Wang, F., Cnop, M., Prigeon, R.L. and Kahn, S.E. (2003) Increased dietary fat promotes islet amyloid formation and β-cell secretory dysfunction in a transgenic mouse model of islet amyloid. Diabetes 52, 372-379
37. Vidal, J., Verchere, C.B., Andrikopoulos, S., Wang, F., Hull, R.L., Cnop, M., Olin, K.L., LeBoeuf, R.C., O'Brien, K.D., Chait, A. and Kahn, S.E. (2003) The effect of apolipoprotein E deficiency on islet amyloid deposition in human islet amyloid polypeptide transgenic mice. Diabetologia 46, 71-79
38. Wang, F., Hull, R.L., Vidal, J., Cnop, M. and Kahn, S.E. (2001) Islet amyloid develops diffusely throughout the pancreas before becoming severe and replacing endocrine cells. Diabetes 50, 2514-2520
39. Lee, Y., Hirose, H., Ohneda, M., Johnson, J.H., McGarry, J.D. and Unger, R.H. (1994) β-Cell lipotoxicity in the pathogenesis of non-insulin- dependent diabetes mellitus of obese rats: impairment in adipocyte-β-cell relationships. Proc. Natl. Acad. Sci. U.S.A. 91, 10878-10882
40. Lee, Y., Hirose, H., Zhou, Y.T., Esser, V., McGarry, J.D. and Unger, R.H. (1997) Increased lipogenic capacity of the islets of obese rats: a role in the pathogenesis of NIDDM. Diabetes 46, 408-413
41. Shimabukuro, M., Ohneda, M., Lee, Y. and Unger, R.H. (1997) Role of nitric oxide in obesity-induced β-cell disease. J. Clin. Invest. 100, 290-295
42. Maedler, K., Oberholzer, J., Bucher, P., Spinas, G.A. and Donath, M.Y. (2003) Monounsaturated fatty acids prevent the deleterious effects of palmitate and high glucose on human pancreatic β-cell turnover and function. Diabetes 52, 726-733
43. Busch, A.K., Gurisik, E., Cordery, D.V., Sudlow, M., Denyer, G.S., Laybutt, D.R., Hughes, W.E. and Biden, T.J. (2005) Increased fatty acid desaturation and enhanced expression of stearoyl coenzyme A desaturase protects pancreatic β-cells from lipoapoptosis. Diabetes 54, 2917-2924
44. Eizirik, D.L. and Mandrup-Poulsen, T. (2001) A choice of death: the signal-transduction of immune-mediated β-cell apoptosis. Diabetologia 44, 2115-2133
45. Cnop, M., Welsh, N., Jonas, J.C., Jörns, A., Lenzen, S. and Eizirik, D.L. (2005) Mechanisms of pancreatic β-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes 54 (Suppl. 2), S97-S107
46. Welsh, N., Cnop, M., Kharroubi, I., Bugliani, M., Lupi, R., Marchetti, P. and Eizirik, D.L. (2005) Is there a role for locally produced interleukin-1 in the deleterious effects of high glucose or the type 2 diabetes milieu to human pancreatic islets? Diabetes 54, 3238-3244
47. Shoelson, S.E., Lee, J. and Goldfine, A.B. (2006) Inflammation and insulin resistance. J. Clin. Invest. 116, 1793-1801
48. El-Assaad, W., Buteau, J., Peyot, M.L., Nolan, C., Roduit, R., Hardy, S., Joly, E., Dbaibo, G., Rosenberg, L. and Prentki, M. (2003) Saturated fatty acids synergize with elevated glucose to cause pancreatic β-cell death. Endocrinology 144, 4154-4163
49. Hellemans, K., Kerckhofs, K., Hannaert, J.C., Martens, G., Van Veldhoven, P. and Pipeleers, D. (2007) Peroxisome proliferator-activated receptor α-retinoid X receptor agonists induce β-cell protection against palmitate toxicity. FEBS J. 274, 6094-6105
50. Cnop, M., Ladriere, L., Hekerman, P., Ortis, F., Cardozo, A.K., Dogusan, Z., Flamez, D., Boyce, M., Yuan, J. and Eizirik, D.L. (2007) Selective inhibition of eukaryotic translation initiation factor 2α dephosphorylation potentiates fatty acid-induced endoplasmic reticulum stress and causes pancreatic β-cell dysfunction and apoptosis. J. Biol. Chem. 282, 3989-3997
51. Hartman, M.G., Lu, D., Kim, M.L., Kociba, G.J., Shukri, T., Buteau, J., Wang, X., Frankel, W.L., Guttridge, D., Prentki, M. et al. (2004) Role for activating transcription factor 3 in stress-induced β-cell apoptosis. Mol. Cell. Biol. 24, 5721-5732
52. Huang, C.J., Lin, C.Y., Haataja, L., Gurlo, T., Butler, A.E., Rizza, R.A. and Butler, P.C. (2007) High expression rates of human islet amyloid polypeptide induce endoplasmic reticulum stress mediated β-cell apoptosis, a characteristic of humans with type 2 but not type 1 diabetes. Diabetes 56, 2016-2027
53. Laybutt, D.R., Preston, A.M., Akerfeldt, M.C., Kench, J.G., Busch, A.K., Biankin, A.V. and Biden, T.J. (2007) Endoplasmic reticulum stress contributes to β-cell apoptosis in type 2 diabetes. Diabetologia 50, 752-763
54. Marchetti, P., Bugliani, M., Lupi, R., Marselli, L., Masini, M., Boggi, U., Filipponi, F., Weir, G.C., Eizirik, D.L. and Cnop, M. (2007) The endoplasmic reticulum m pancreatic β-cells of type 2 diabetes patients. Diabetologia 50, 2486-2494
55. Delepine, M., Nicolino, M., Barrett, T., Golamaully, M., Lathrop, G.M. and Julier, C. (2000) EIF2AK3, encoding translation initiation factor 2-α kinase 3, is mutated in patients with Wolcott-Rallison syndrome. Nat. Genet. 25, 406-409
56. Inoue, H., Tanizawa, Y., Wasson, J., Behn, P., Kalidas, K., Bernal-Mizrachi, E., Mueckler, M., Marshall, H., Donis-Keller, H., Crock, P. et al. (1998) A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome). Nat. Genet. 20, 143-148
57. Stoy, J., Edghill, E.L., Flanagan, S.E., Ye, H., Paz, V.P., Pluzhnikov, A., Below, J.E., Hayes, M.G., Cox, N.J., Lipkind, G.M. et al. (2007) Insulin gene mutations as a cause of permanent neonatal diabetes. Proc. Natl. Acad. Sci. U.S.A. 104, 15040-15044
58. Nakatani, Y., Kaneto, H., Kawamori, D., Yoshiuchi, K., Hatazaki, M., Matsuoka, T.A., Ozawa, K., Ogawa, S., Hori, M., Yamasaki, Y. and Matsuhisa, M. (2005) Involvement of endoplasmic reticulum stress in insulin resistance and diabetes. J. Biol. Chem. 280, 847-851
59. Ozcan, U., Cao, Q., Yilmaz, E., Lee, A.H., Iwakoshi, N.N., Ozdelen, E., Tuncman, G., Gorgun, C., Glimcher, L.H. and Hotamisligil, G.S. (2004) Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 306, 457-461
60. Eizirik, D.L., Cardozo, A.K. and Cnop, M. (2008) The role for endoplasmic reticulum stress in diabetes mellitus. Endocr. Rev. 29, 42-61
61. Cnop, M., Havel, P.J., Utzschneider, K.M., Carr, D.B., Sinha, M.K., Boyko, E.J., Retzlaff, B.M., Knopp, R.H., Brunzell, J.D. and Kahn, S.E. (2003) Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex Diabetologia 46, 459-469
62. Cnop, M., Landchild, M.J., Vidal, J., Havel, P.J., Knowles, N.G., Carr, D.R., Wang, F., Hull, R.L., Boyko, E.J., Retzlaff, B.M. et al. (2002) The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations: distinct metabolic effects of two fat compartments. Diabetes 51, 1005-1015
63. Nieves, D.J., Cnop, M., Retzlaff, B., Walden, C.E., Brunzell, J.D., Knopp, R.H. and Kahn, S.E. (2003) The atherogenic lipoprotein profile associated with obesity and insulin resistance is largely attributable to intra-abdominal fat. Diabetes 52, 172-179